Critical ligand binding reagent preparation/selection: When specificity depends on reagents

AAPS Journal

Volumn 9, Issue 2, 2007, Pages

  Rup, Bonita ^a   O'Hara, Denise ^a  

^a PFIZER INC   (United States)

Author keywords

Assay specificity; Ligand binding reagents; Reagent characterization

Indexed keywords

APTAMER; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; REAGENT; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SYNTHETIC PEPTIDE;

ANALYTIC METHOD; ARTICLE; BIOASSAY; CHEMICAL MODIFICATION; CONJUGATION; DRUG DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMMUNOGENICITY; LIGAND BINDING; NONHUMAN; PROCESS OPTIMIZATION; PURIFICATION; SENSITIVITY AND SPECIFICITY; STORAGE; SURFACE PLASMON RESONANCE;

ANTIBODIES, MONOCLONAL; IMMUNOASSAY; INDICATORS AND REAGENTS; LIGANDS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34249307306     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/aapsj0902016     Document Type: Article

References (29)

1. Porstmann T, Kiessig ST. Enzyme immunoassay techniques. J Immunol Methods. 1992;150:5-21.
2. Findlay JWA, Smith WC, Lee JW, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biol. 2000;21:1249-1273.
3. DeSilva B, Smith W, Weiner R, et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res. 2003;20:1885-1900.
4. Mire-Sluis AR, Barrett YC, Devanarayan V, et al. Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. J Immunol Methods. 2004;289:1-16.
5. Geng D, Shankar G, Schantz A, Rajadhyaksha M, Davis H, Wagner C. Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies. J Pharm Biol. 2005;39:364-375.
6. Smolec J, DeSilva B, Smith W, et al. Bioanalytical method validation for macromolecules in support of pharmacokinetic studies. Pharm Res. 2005;22:1425-1431.
7. Shankar G, Shores E, Wagner C, Mire-Sluis A. Scientific and regulatory considerations on the immunogenicity of biologics. Trends Biotechnol. 2006;24:274-280.
8. Tang L, Persky AM, Hochhaus G, Meibohm B. Pharmacokinetic aspects of biotechnology products. J Pharma Sci. 2004;93:2184-2204.
9. Coleman PM. Structure of antibody-antigen complexes: implications of immune recognition. Adv Immunol. 1988;43:99-132.
10. Butler JE. Perspectives, Configurations and Principles: Immunochemistry of Solid-phase Immunoassays. Boca Raton, FL: CRC Press; 1991:3-26.
11. Tijssen P. Laboratory Techniques in Biochemistry and Molecular Biology. San Diego, CA: Elsevier Science Publishers; 1985.
12. Gosling JB, ed. Immunoassays: A Practical Approach. Oxford, UK: Oxford University Press; 2000.
13. Burns R. Immunochemical Protocols. Totowa, NJ: Humana Press; 2005.
14. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495-497.
15. Howard GC, Bethell DR. Basic Methods in Antibody Production and Characterization. Boca Raton, FL: CRC Press; 2001.
16. Subramanian G. Antibodies. Vol 2. Novel Technologies and Therapeutic Use. New York, NY: Kluwer Academic/Plenum Publishers; 2004.
17. Bradbury AR, Mark JD. Antibodies from phage antibody libraries. J Immunol Methods. 2004;290:29-49.
18. Lipovsek D, Pluckthun AJ. In-vitro protein evolution by ribosome display and mRNA display. Immunol Meth. 2004;290:51-67.
19. Konthur Z, Hust M, Dubel S. Perspectives for systematic in vitro antibody generation. Gene. 2005;364:19-29.
20. Brody EN, Gold LJ. Aptamers as therapeutic and diagnostic agents. J Biotechnol. 2000;74:5-13.
21. Nord K, Gunneriusson E, Ringdahl J, Stahl S, Uhlen M, Nygren PA. Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain. Nat Biotechnol. 1997;15:772-777.
22. Engelbienne P. Immune and Receptor Assays in Theory and Practice. Boca Raton, FL: CRC Press; 2000.
23. Wong SS. Chemistry of Protein Conjugation and Cross-linking. Boca Raton, FL: CRC Press; 2000.
24. Niemeyer CM. Bioconjugation Protocols: Strategies and Methods. Totowa, NJ: Humana Press; 2004:283.
25. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 1994;8:133-146.
26. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res. 1998;346:26-37.
27. Webb DJ, Wen J, Karns LR, Kurilla MG, Gonias SL. Localization of the binding site for transforming growth factor-B in human alpha-2-macroglobulin to a 20-kDa peptide that also contains the bait region. J Biol Chem. 1998;273:13339-13346.
28. Blum WF, Ranke MB. Plasma IGFBP-3 levels as clinical indicators. In: Spencer EM, ed. Modern Concepts of Insulin-Like Growth Factors. New York, NY: Elsevier Science Publishing Co; 1991:381-393.
29. Harrison D, Celniker A, Reifsnyder D, Sipes D, Schroeder K, Gesundheit N. Measurement of serum insulin-like growth factor binding protein 3 using a two-site ELISA. Abstract 970 presented at: The 74th Endocrine Society Meeting; June 24-27, 1992; San Antonio, TX.